genie lamp drawing
genie lamp drawing
Four Canadian women honoured in World Rugby's Dream Teams of the YearBOSTON, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Block & Leviton announces that a securities fraud lawsuit has been filed against Kyverna Therapeutics, Inc. (Nasdaq: KYTX) and certain of its executives. Investors who have lost money in their Kyverna Therapeutics, Inc. investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/kytx . What is this all about? Kyverna Therapeutics has been sued for securities law violations. The lawsuit alleges that at the time of the company's February 2024 IPO, it knew adverse data about one of Kyverna's drug trials, which it kept from the market, in violation of federal securities laws. Those who purchased Kyverna shares traceable to the company's IPO may be eligible to recover for their losses. Who is eligible? Anyone who purchased Kyverna Therapeutics, Inc. common stock between February 07, 2024 and December 09, 2024 and has seen their shares fall may be eligible, whether or not they have sold their investment. Investors should contact Block & Leviton to learn more. What should you do next? The deadline to seek appointment as lead plaintiff is February 07, 2025. A class has not yet been certified, and until a certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member. If you've lost money on your investment, you should contact Block & Leviton to learn more via our case website , by email at shareholders@blockleviton.com , or by phone at (888) 256-2510. Whistleblower? If you have non-public information about Kyverna Therapeutics, Inc., you should consider assisting in our investigation or working with our attorneys to file a report with the Securities Exchange Commission under their whistleblower program. Whistleblowers who provide original information to the SEC may receive rewards of up to 30% of any successful recovery. For more information, contact Block & Leviton at whistleblowers@blockleviton.com or by phone at (888) 256-2510. Why should you contact Block & Leviton? Block & Leviton is widely regarded as one of the leading securities class action firms in the country. Our attorneys have recovered billions of dollars for defrauded investors and are dedicated to obtaining significant recoveries on behalf of our clients through active litigation in the federal courts across the country. Many of the nation's top institutional investors hire us to represent their interests. You can learn more about us at our website, www.blockleviton.com , call (888) 256-2510 or email shareholders@blockleviton.com with any questions. This notice may constitute attorney advertising. CONTACT: BLOCK & LEVITON LLP 260 Franklin St., Suite 1860 Boston, MA 02110 Phone: (888) 256-2510 Email: shareholders@blockleviton.com
Blanton also had six rebounds for the Colonels (4-2). Mayar Wol scored 14 points while going 4 of 11 from the floor, including 3 for 7 from 3-point range, and 3 for 4 from the line and added five rebounds. George Kimble III had 13 points and shot 4 for 12 (2 for 5 from 3-point range) and 3 of 4 from the free-throw line. Ali Abdou Dibba led the Salukis (2-5) in scoring, finishing with 26 points. Southern Illinois also got 21 points, seven rebounds and two steals from Kennard Davis. Drew Steffe also had 10 points. Eastern Kentucky went into halftime leading Southern Illinois 48-22. Kimble scored 12 points in the half. Eastern Kentucky turned an 11-point second-half lead into an 18-point advantage with an 8-1 run to make it a 65-47 lead. Montavious Myrick scored nine second-half points. The Associated Press created this story using technology provided by Data Skrive and data from Sportradar .
Atlantic County towns net $2.5 million in pedestrian safety grants
Trump Cabinet picks, appointees targeted by bomb threats and swatting attacksColorado's winter huts blend adventure, luxury, and scenic beauty.5 top tech gifts for the holidays
Stock market today: Wall Street hits records despite tariff talkA Farmingdale High School and Stony Brook University graduate is President-elect Donald Trump’s pick to oversee the Centers for Disease Control and Prevention, and if confirmed, he’d replace another Long Island native. The nomination of Dr. Dave Weldon, a former Republican congressman from Florida, has provoked concern from public health experts. He sponsored a bill to limit the use of vaccines containing mercury because of concerns the mercury-based preservative thimerosal could cause autism despite the CDC’s and leading health experts’ insistence that it does not, and sponsored a 2007 bill to strip the CDC of vaccine-safety responsibilities and move it to another agency within the Department of Health and Human Services. He would replace Dr. Mandy Cohen, a Baldwin native who in a statement released by the CDC after vaccine critic Robert F. Kennedy Jr.’s nomination for secretary of health and human services, but before Weldon’s, wrote: "I don't want to go backward and see children or adults suffer or lose their lives to remind us that vaccines work, and so I am concerned. Any misinformation coming from places of influence or power are concerning." K.C. Rondello, a clinical associate professor of public health at Adelphi University in Garden City, said in an email that he and others working in public health "are tremendously concerned about the potential impact of appointing a vaccine skeptic and conspiracy theorist to the role of CDC director. [Former] Rep. Weldon espouses beliefs that are contrary to the overwhelming mountain of evidence on vaccine efficacy and safety that has been garnered over decades." The CDC states that many studies have examined potential links between vaccines and autism and "continue to show that vaccines are not associated with ASD," or autism spectrum disorder. Children’s Health Defense, an organization that Kennedy founded, said in a statement: "We believe Dr. Weldon is eminently qualified as a former member of Congress and physician." The organization referred Newsday to an article on its website in which critics of the CDC praised Weldon for his criticism of the CDC’s vaccine safety oversight. Weldon was not available to comment, a Trump transition team spokeswoman said in an email. Weldon was born in Amityville, according to his official congressional biography , and graduated from Farmingdale High in 1971. He was among the first 16 Farmingdale alumni with their names inscribed on the school’s Wall of Honor, Newsday reported in 1998. He graduated from Stony Brook in 1978 with a bachelor of science in biochemistry, earning "high honors," university records show. He received his medical degree from the University at Buffalo in 1981. Weldon was a part-time clinical professor at the Florida Institute of Technology in Melbourne, Florida, from 2012 to 2019, and served on the university’s board of trustees from 2021 until January, the university said in an email. Weldon represented an east-central Florida congressional district from 1995 to 2009. His 2004 bill regarding thimerosal didn't pass. Thimerosal is added to vaccines to prevent germ growth and, according to the CDC , contains a type of mercury different than the one that is found in some fish. Studies have shown that low doses of thimerosal in vaccines are not harmful, other than minor reactions like redness at the injection site. Thimerosal was removed from childhood vaccines in 2001. It is in flu vaccines for adults and children, but there are thimerosal-free options. Weldon also has expressed concern about the safety of other vaccines, including those against measles, mumps and rubella, multiple news reports said. Dorit R. Reiss, a professor at University of California Law San Francisco and an expert on vaccine policy and law, said, "Weldon isn’t quite as extreme as Kennedy." But, she said, she is concerned that Weldon would push to no longer recommend certain vaccines and change CDC vaccine guidance. A committee of medical and public health experts, the Advisory Committee on Immunization Practices , advises the CDC on vaccines, but the CDC director can reject those recommendations, Reiss said. In addition, as health and human services secretary, Kennedy would have the power to appoint committee members. Recommendations are critical, because states generally follow them, she said. "Given the way this topic is politicized — which is a really sad thing, because viruses don't care about your politics — if the recommendations change suddenly, the reception would probably vary across states by political approach, and we may end up with a tragic national experiment in which some states stop recommending some vaccines and others don’t," Reiss said. In addition, the Affordable Care Act requires that most insurance plans pay for CDC-recommended vaccines if administered in-network. Many people won’t take vaccines if they must pay for them, Reiss said. "Some [insurance companies] will continue to cover vaccines that are not recommended because it's more cost effective for them to prevent disease than to treat it, but some won’t," she said. The CDC releases other advisories and recommendations. For example, the CDC website currently states that research shows that vaccines do not cause autism. If that changed, it could affect public trust in the CDC and put an official government stamp on baseless information, she said. A Farmingdale High School and Stony Brook University graduate is President-elect Donald Trump’s pick to oversee the Centers for Disease Control and Prevention, and if confirmed, he’d replace another Long Island native. The nomination of Dr. Dave Weldon, a former Republican congressman from Florida, has provoked concern from public health experts. He sponsored a bill to limit the use of vaccines containing mercury because of concerns the mercury-based preservative thimerosal could cause autism despite the CDC’s and leading health experts’ insistence that it does not, and sponsored a 2007 bill to strip the CDC of vaccine-safety responsibilities and move it to another agency within the Department of Health and Human Services. He would replace Dr. Mandy Cohen, a Baldwin native who in a statement released by the CDC after vaccine critic Robert F. Kennedy Jr.’s nomination for secretary of health and human services, but before Weldon’s, wrote: "I don't want to go backward and see children or adults suffer or lose their lives to remind us that vaccines work, and so I am concerned. Any misinformation coming from places of influence or power are concerning." K.C. Rondello, a clinical associate professor of public health at Adelphi University in Garden City, said in an email that he and others working in public health "are tremendously concerned about the potential impact of appointing a vaccine skeptic and conspiracy theorist to the role of CDC director. [Former] Rep. Weldon espouses beliefs that are contrary to the overwhelming mountain of evidence on vaccine efficacy and safety that has been garnered over decades." WHAT NEWSDAY FOUND The CDC states that many studies have examined potential links between vaccines and autism and "continue to show that vaccines are not associated with ASD," or autism spectrum disorder. Get the latest stories every week about health and wellness, covering topics from medicine and mental health to updates on the coronavirus and new research. By clicking Sign up, you agree to our privacy policy . Children’s Health Defense, an organization that Kennedy founded, said in a statement: "We believe Dr. Weldon is eminently qualified as a former member of Congress and physician." The organization referred Newsday to an article on its website in which critics of the CDC praised Weldon for his criticism of the CDC’s vaccine safety oversight. Weldon was not available to comment, a Trump transition team spokeswoman said in an email. Weldon was born in Amityville, according to his official congressional biography , and graduated from Farmingdale High in 1971. He was among the first 16 Farmingdale alumni with their names inscribed on the school’s Wall of Honor, Newsday reported in 1998. He graduated from Stony Brook in 1978 with a bachelor of science in biochemistry, earning "high honors," university records show. He received his medical degree from the University at Buffalo in 1981. Weldon was a part-time clinical professor at the Florida Institute of Technology in Melbourne, Florida, from 2012 to 2019, and served on the university’s board of trustees from 2021 until January, the university said in an email. Weldon represented an east-central Florida congressional district from 1995 to 2009. His 2004 bill regarding thimerosal didn't pass. Thimerosal is added to vaccines to prevent germ growth and, according to the CDC , contains a type of mercury different than the one that is found in some fish. Studies have shown that low doses of thimerosal in vaccines are not harmful, other than minor reactions like redness at the injection site. Thimerosal was removed from childhood vaccines in 2001. It is in flu vaccines for adults and children, but there are thimerosal-free options. Weldon also has expressed concern about the safety of other vaccines, including those against measles, mumps and rubella, multiple news reports said. Dorit R. Reiss, a professor at University of California Law San Francisco and an expert on vaccine policy and law, said, "Weldon isn’t quite as extreme as Kennedy." But, she said, she is concerned that Weldon would push to no longer recommend certain vaccines and change CDC vaccine guidance. A committee of medical and public health experts, the Advisory Committee on Immunization Practices , advises the CDC on vaccines, but the CDC director can reject those recommendations, Reiss said. In addition, as health and human services secretary, Kennedy would have the power to appoint committee members. Recommendations are critical, because states generally follow them, she said. "Given the way this topic is politicized — which is a really sad thing, because viruses don't care about your politics — if the recommendations change suddenly, the reception would probably vary across states by political approach, and we may end up with a tragic national experiment in which some states stop recommending some vaccines and others don’t," Reiss said. In addition, the Affordable Care Act requires that most insurance plans pay for CDC-recommended vaccines if administered in-network. Many people won’t take vaccines if they must pay for them, Reiss said. "Some [insurance companies] will continue to cover vaccines that are not recommended because it's more cost effective for them to prevent disease than to treat it, but some won’t," she said. The CDC releases other advisories and recommendations. For example, the CDC website currently states that research shows that vaccines do not cause autism. If that changed, it could affect public trust in the CDC and put an official government stamp on baseless information, she said. David Olson covers health care. He has worked at Newsday since 2015 and previously covered immigration, multicultural issues and religion at The Press-Enterprise in Southern California.Ukraine’s allies have shifted their focus from seeking a victory to trying to put President Volodymyr Zelenskyy in the best position to counter Russian advances or negotiate a possible ceasefire, people familiar with the matter said. For now, that means NATO is redoubling efforts to rush more weapons to the war-torn country as Kyiv forces are slowly losing ground, raising the specter the eventual truce may freeze the conflict with swathes of Ukraine under occupation by Vladimir Putin’s troops. Putin has shown no willingness to discuss a ceasefire, but the return of Donald Trump to the White House has focused NATO allies on how to shore up the political will to sustain the nearly three-year war as morale starts to fade. As foreign ministers gathered in Brussels this week have focused on how to supply more weapons, governments have begun considering various negotiated scenarios to end the war, the people said. The discussion includes the kind of security guarantees that would protect Ukraine, while not provoking Putin, the people said. All of them spoke on the condition of anonymity given the political and security sensitivity of the planning, which is private and still incomplete. One possible option for a cease-fire includes creating a demilitarized zone. In case of a cease-fire, European troops would probably secure and patrol it, according to one senior NATO diplomat. Those discussions come amid recognition that the situation in Ukraine is unsustainable and negotiations should begin soon, according to another senior western diplomat. For European allies, the scenarios also offer an opportunity to show Trump they can stay relevant if cease-fire talks eventually crystallize. The private considerations over how the war may end took place as NATO’s secretary general, Mark Rutte, tried on Wednesday to keep the focus on surging weapons to Ukraine, setting aside for now the contours of any cease-fire. “We must do more than just keep Ukraine in the fight,” Rutte said in his closing remarks at the NATO meeting. “We must provide enough support to change the trajectory of this war once and for all.” “Changing the trajectory means that where the frontline is now moving westwards we have to make sure that Ukraine is in a position of strength” when it comes to potential talks, he added. Zelenskyy himself signaled in recent interviews that a diplomatic solution is needed and that he’d accept an end to hostilities with parts of eastern Ukraine occupied, an outcome recent polls have shown a majority of Ukrainians would tolerate. “Zelenskyy’s acknowledgment that Ukraine won’t be able to liberate all Russian-occupied territory militarily is more than a recognition of reality,” said Lucian Kim, International Crisis Group analyst and author of recently published Putin’s Revenge: Why Russia Invaded Ukraine. “It is also an opening to future peace efforts by a second Trump administration.” The key for Zelenskyy — and the complication for NATO — is his request that the alliance provide security guarantees over the portions of the country that Kyiv still controls, as well as the uncertain possibility of regaining that territory later through diplomacy. The Ukrainian president said on Sunday that any invitation to join the alliance must apply to his entire country, within its internationally recognized borders. His country’s previous experience with security guarantees, provided jointly by Russia, the U.S. and Britain by the Budapest Memorandum in 1994 in return for Kyiv giving up its Soviet-era nuclear arsenal, proved worthless when Putin invaded. Membership for Ukraine in NATO — with its security guarantee that a war against one is a war against all — is out of the question in the short term. It would also be a red line for Putin, who sees NATO on Russia’s border as a threat and Ukraine ultimately a part of his sphere of influence. Instead, Kyiv would need security guarantees that potentially bind the U.S. or other allies to come to its defense if Russia were to breach any cease-fire. Those would go beyond the commitments by the U.S. and dozens of allies to bolster Ukraine’s military over the long term, including with training. One goal of bulking up Kyiv’s military, and allowing it to strike deeper into Russia with western weapons, is to convince Putin that talks are better than fighting, which now is unlikely with Russian forces continuing to advance. “We don’t want to sugarcoat anything,” General Christian Freuding, head of the German Defense Ministry’s planning and command staff, said in comments posted online. Russia is taking the initiative “on all fronts, in all areas” and making continuous territorial gains. That includes on the eastern transport hub of Pokrovsk, which he sees Ukrainian forces needing to abandon by early next year. According to a NATO senior official, the pace of Russia’s advances is increasing, putting Ukrainian frontlines under additional pressure. And while Russia is sustaining casualties of about 1,500 killed and wounded a day, they have also been able to recruit around 30,000 new personnel a month, cementing the country’s manpower advantage. “Putin is clearly in the lead and doesn’t particularly want any negotiations,” Estonia’s ambassador to NATO, Juri Luik, said in an interview with the nation’s public broadcaster ERR. Worries within the administration of outgoing President Joe Biden that a Russian victory would embolden Moscow allies China, Iran and North Korea are at least partly behind the renewed surge of artillery shells, missiles, land mines and air defense systems. NATO’s Rutte said in an interview with the Financial Times this week that he delivered a similar warning to Trump about America’s rivals when he visited the president-elect recently in Florida. Even without a shift to Trump, who has criticized the billions the U.S. has pledged to support Ukraine, dwindling manpower and weapons mean talks would need to begin next year anyway, according to Samuel Charap, a senior political scientist at Rand. “Ukraine lacks the manpower to stop the Russian offensive, and the west has little left to give in terms of existing stocks of weapons,” Charap said. U.S. Secretary of State Antony Blinken landed in Brussels this week, planning to discuss how to protect Ukraine over the long term, despite his short time left. “You’ve got me, you’ve got us,” Blinken told Rutte before their meeting. “Until the 20th of January,” he added, referring to Biden’s last day in office.
Finding the perfect gift can be daunting. The only way to truly ensure you get it right would be to ask the recipient what they want, but that wouldn’t be much fun for either of you. Luckily, there’s another tactic to help you earn a “gift whisperer” reputation: seeking out unique, practical, game-changing gifts that will truly surprise and delight. But that’s about as easy as it sounds, which is to say it’s not easy at all. So, we’ve done the legwork for you. Start making your list with this compilation of some of the most innovative, functional and fun gifts of 2024. There’s something for every budget. This image provided by FinaMill shows the FinaMill Ultimate Spice Grinder Set. The new FinaMill Ultimate Spice Grinder set elevates the pedestrian pepper and spice mill in both function and style. Bear with me: The new FinaMill Ultimate Spice Grinder set elevates the pedestrian pepper and spice mill in both function and style. Available in three colors (Sangria Red, Midnight Black and Soft Cream), the rechargeable-battery unit grinds with a light touch rather than hand-tiring twists. That’s easier for everyone and especially helpful for those experiencing hand or wrist issues such as arthritis, carpal tunnel syndrome or tendinitis. And it’s fun to use. The set includes a stackable storage tray and four pods that can be easily swapped as needed: The GT microplane grater for hard spices, nuts and chocolate; the MAX for large spices and dried herbs; the ProPlus for smaller and oily spices; and the Pepper Pod for, well, pepper. $110. This image provided by Pull Start Fire shows the matchless fire igniter in use. Made of 89% recycled materials, the food-safe, eco-friendly, 3-by-2-by-1-inch fire starters will light a fire quickly without matches, lighters or kindling. Campers and backyard firepit lovers who have experienced the heartbreak of wet wood will appreciate having a three-pack of Pull Start Fire on hand. Made of 89% recycled materials, including sanding dust, wax and flint, the food-safe, eco-friendly, 3-by-2-by-1-inch fire starters will light a fire quickly without matches, lighters or kindling. Just loop the attached green string around a log, incorporate it into a wood stack, and pull the attached red string to ignite. Each windproof, rainproof block burns for 30 minutes. $29.99. This image provided by Souper Cubes shows No Mess Utensils held upright on pot edges. The No Mess Utensil lives up to its name. The utensils, a serving spoon and a ladle, have innovative, S-shaped handles designed to rest on the edge of a pot. The No Mess Utensil Set from Souper Cubes , a company known for its portioned, silicone freezer trays, lives up to its name. The utensils — a serving spoon and a ladle — have innovative, S-shaped handles designed to rest on the edge of a pot, keeping them upright so they won’t slip in. The design also eliminates the need for a spoon rest or, worse, placing dirty utensils on the kitchen counter or stovetop between stirs. A silicone coating in a choice of Aqua, Charcoal, Cranberry or Blueberry keeps handles cool to the touch. $24.99. This image provided by FeatherSnap shows a female cardinal bird perched on a FeatherSnap Wi-Fi Solar Powered Camera Smart Bird Feeder. Equipped with an HD camera, the dual-chamber feeder enables up-close livestreaming of avian visitors, as well as species-logging via the free mobile app. The FeatherSnap Wi-Fi smart bird feeder could turn anyone into an avid birdwatcher. Equipped with an HD camera, the dual-chamber feeder enables up-close livestreaming of avian visitors, as well as species-logging via the free mobile app. An optional premium subscription ($59.99 annually or $6.99 monthly) includes unlimited photo and video storage, AI identification with species-specific details, and the opportunity to earn badges for logging new visitors. Turn on notifications to get alerts sent to your phone whenever there’s activity at the feeder. $179.99. This image provided by FUJIFILM North America Corporation and FUJIFILM Corporation Tokyo shows a smartphone printer. Fujifilm Instax's Mini Link 3 smartphone printer offers a touch of nostalgia without sacrificing technology. Just load the printer with film and connect it to your Android or iOS device via Bluetooth to print wallet-size photos. Fujifilm's Instax Mini Link 3 smartphone printer offers a touch of nostalgia without sacrificing technology. Just load the 4.9-by-3.5-by-1.3-inch printer with Instax Mini instant film and connect it to your Android or iOS device via Bluetooth to print wallet-size photos. If you want to get fancy, you can adjust brightness, contrast and saturation, or apply filters, including 3D augmented-reality effects, via the free Instax Mini Link app. It can also make collages of up to six images, or animate photos to share on social media. Available in Rose Pink, Clay White and Sage Green. $99.95. This image provided by easyplant shows a Marxii Calathea plant in a small, beige, self-watering pot. The appropriately named easyplant is one of the best gifts you can give your houseplant-loving friends, regardless of their experience level. The appropriately named easyplant is one of the best gifts you can give your houseplant-loving friends, regardless of their experience level. Select a pot color, size and plant (or get recommendations based on sunlight requirements, pet friendliness and other attributes) and fill the self-watering container’s built-in reservoir roughly once a month. Moisture will permeate the soil from the bottom as needed, eliminating the often-fatal consequences of over- or under-watering. It’s also a literal lifesaver come vacation time. $49-$259. This image provided by Nama shows the M1 plant-based milk maker. If you've got a no-dairy friend on your list, a plant-based milk maker could save them money while allowing them to avoid unnecessary ingredients like sugar, stabilizers, thickeners and preservatives. If you’ve got a no-dairy friend on your list, a plant-based milk maker could save them money while allowing them to avoid sugar, stabilizers, thickeners and preservatives. The Nama M1 appliance both blends and strains ingredients, converting nuts, seeds, grains or oats into velvety-smooth milk in just one minute, with zero grit. And for zero waste, the pasty leftover pulp can be used in other recipes for added nutrients. The device also makes infused oils, flavored waters and soups. And, importantly, cleanup is easy. Available in white and black. $400. This image provided by QelviQ shows a wine bottle chiller. For friends who prefer stronger beverages, the QelviQ personal sommelier uses "smart" technology to ensure wine is served at its ideal temperature. For friends who prefer stronger beverages, the QelviQ personal sommelier uses “smart” technology to ensure wine is served at its ideal temperature. Unlike traditional wine refrigerators, this device doesn’t take up any floor space. It also doesn’t chill wine to just one or two temperatures based on its color. Instead — paired with the free QelviQ app — the tabletop chiller relies on a database of more than 350,000 wines to bring a bottle to its specific recommended serving temperature in as little as 20 minutes. It also suggests food-wine and wine-food pairings. Plus, the appliance serves as a great icebreaker to inspire dinnertime conversation. Available in Exciting Red, Dashing Black and Dreamy White. $495. This image provided by Uncommon Goods shows a 2-piece LED Grilling Tool Set. Uncommon Good's 2-piece LED Grilling Tool Set puts illumination into the handles of its stainless-steel spatula and tongs. Grilling food after dark — and ascertaining its doneness — can prove challenging without outdoor lighting, and it’s nearly impossible to cook while holding a flashlight. But as is often the case, the simplest of solutions can make the biggest of impacts: Uncommon Good’s 2-piece LED Grilling Tool Set puts illumination into the handles of its stainless-steel spatula and tongs. After use, the lights can be removed and the utensils run through the dishwasher. $40. Copyright 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission. With our weekly newsletter packed with the latest in everything food.Pedestrian struck in northeast LondonHurricanes star Cam Ward named ACC Player of the Year
Harry Potter’s Ralph Fiennes Supports This Voldemort Recasting (But Will It Happen?)
WASHINGTON, Nov. 26, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today issued the following statement in response to a short seller report published on November 26, 2024 by Fuzzy Panda Research (“Fuzzy Panda”). Fuzzy Panda is a self-proclaimed short seller who stands to realize significant gains if the price of ASP Isotopes’s stock declines. Based upon ASP Isotopes’s and its legal counsel’s preliminary review and evaluation of the report, the Company believes the report includes speculative conjecture and claims that are inaccurate or filled with innuendo in an attempt to mislead investors about ASP Isotopes’s technology, leadership and future growth. Investors are encouraged to review the Company’s public filings made with the SEC. ASP Isotopes is in the process of commissioning three isotope enrichment facilities in South Africa and has hosted commercial partners and investors at these facilities. The first facility is scheduled to enrich Carbon-14 for use in healthcare and agrochemicals. The second facility is scheduled to enrich Silicon-28, which the Company believes will enable faster, more efficient semiconductors for use in artificial intelligence and quantum computing. The third facility is scheduled to enrich Ytterbium-176, a critically important raw material used in the production of radio-oncology therapies. ASP Isotopes values transparency and open communication. Canaccord Genuity’s analyst, George Gianarikas, will host a fire side chat with ASP Isotopes’s Chairman and Chief Executive Officer, Paul Mann, at 10am EST on November 27, 2024. Please contact your Canaccord Genuity sales representative for dial in details. About ASP Isotopes Inc. ASP Isotopes Inc. is a development stage advanced materials company dedicated to the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (“ASP technology”). The Company’s initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. The Company also plans to enrich isotopes for the nuclear energy sector using Quantum Enrichment technology that the Company is developing. The Company has isotope enrichment facilities in Pretoria, South Africa, dedicated to the enrichment of isotopes of elements with a low atomic mass (light isotopes). There is a growing demand for isotopes such as Silicon-28 for enabling quantum computing; Molybdenum-100, Molybdenum-98, Zinc-68, Ytterbium-176, and Nickel-64 for new, emerging healthcare applications, as well as Chlorine-37, Lithium-6, Lithium-7 and Uranium-235 for green energy applications. The ASP Technology (Aerodynamic Separation Process) is ideal for enriching low and heavy atomic mass molecules. For more information, please visit www.aspisotopes.com . Forward Looking Statements This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, including, without limitation, statements relating to the future of the Company’s enrichment technologies, the market demand for enriched isotopes, and the commencement of supply of enriched isotopes to customers. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations, and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. Forward-looking statements can be identified by words such as “believes,” “plans,” “anticipates,” “expects,” “estimates,” “projects,” “will,” “may,” “might,” and words of a similar nature. Examples of forward-looking statements include, among others but are not limited to, statements we make regarding expected operating results, such as future revenues and prospects from the potential commercialization of isotopes, future performance under contracts, and our strategies for product development, engaging with potential customers, market position, and financial results. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict, many of which are outside our control. Our actual results, financial condition, and events may differ materially from those indicated in the forward-looking statements based upon a number of factors. Forward-looking statements are not a guarantee of future performance or developments. You are strongly cautioned that reliance on any forward-looking statements involves known and unknown risks and uncertainties. Therefore, you should not rely on any of these forward-looking statements. There are many important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements, including the outcomes of various strategies and projects undertaken by the Company; the potential impact of laws or government regulations or policies in South Africa, the United Kingdom or elsewhere; our reliance on the efforts of third parties; our ability to complete the construction and commissioning of our enrichment plants or to commercialize isotopes using the ASP technology or the Quantum Enrichment Process; our ability to obtain regulatory approvals for the production and distribution of isotopes; the financial terms of any current and future commercial arrangements; our ability to complete certain transactions and realize anticipated benefits from acquisitions; contracts, dependence on our Intellectual Property (IP) rights, certain IP rights of third parties; and the competitive nature of our industry. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise. This press release includes market and industry data and forecasts that we obtained from internal research, publicly available information and industry publications and surveys. Industry publications and surveys generally state that the information contained therein has been obtained from sources believed to be reliable. Unless otherwise noted, statements as to our potential market position relative to other companies are approximated and based on third-party data and internal analysis and estimates as of the date of this press release. We have not independently verified this information, and it could prove inaccurate. Industry and market data could be wrong because of the method by which sources obtained their data and because information cannot always be verified with certainty due to the limits on the availability and reliability of raw data, the voluntary nature of the data-gathering process and other limitations and uncertainties. In addition, we do not know all of the assumptions regarding general economic conditions or growth that were used in preparing the information and forecasts from sources cited herein. No information in this press release should be interpreted as an indication of future success, revenues, results of operation, or stock price. All forward-looking statements herein are qualified by reference to the cautionary statements set forth herein and should not be relied upon. Contacts Jason Assad– Investor relations Email: Jassad@aspisotopes.com Telephone: 561-709-3043
Rosters for the upcoming Four Nations Face-Off tournament between Canada, the United States, Finland, and Sweden are set to be revealed this week and there should be plenty of Oilers involved. Canada will be the team to watch for Oilers fans. Connor McDavid was one of the He will join Sidney Crosby, Nathan MacKinnon, Brad Marchand, Braydon Point, and Cale Makar as the other players who have already been named. Yet, there is also a good chance that two of his Oilers teammates will be able to crack Canada’s roster, as well as another that he will most likely have to play against. Here are all four Oilers players who have a good chance of being named to a Four Nations roster this weekend: Of course, this one goes without saying, with McDavid being the de-facto leader for Team Canada, . This will be the first time that McDavid has represented Canada since he entered the NHL back in 2015. It’s been something that hockey fans have been clamouring for over the past decade and now we will finally see hockey’s best player lace them up alongside Crosby for the very first time. The last time McDavid pulled on the maple leaf was during the 2015 World Juniors, when he scored three goals and 11 points in seven games. A slow start to the season may have made Zach Hyman’s involvement with Team Canada a little less obvious than expected, but there is a good chance he still makes the cut. The 32-year-old is coming off a 54-goal season last season and managed an additional 16 during Edmonton’s run to the Stanley Cup Final. The goals have been a bit harder to come by, but there is no question that Team Canada’s brass will be taking last season’s results into consideration. He also has the good fortune of having the most experience playing on McDavid’s wing over the past couple of seasons, making him the perfect candidate to take over the Chris Kunitz role that Canada employed with Crosby in the 2010s. While Oilers fans have their eye on Team Canada’s roster, they should also spend some time getting to know the opposition. Mattias Ekholm will almost certainly lace them up for Team Sweden at the tournament, possibly in a top-four role. Ekholm possesses a stellar two-way game that sees him succeed at both ends of the ice, which puts him in the conversation of being one of the NHL’s very best defenders. He will have solid competition on the left side with Victor Hedman and Gustav Forsling, but he should absolutely be on the roster. Similar to Hyman, Evan Bouchard’s early-season struggles have put a bit of a damper on his potential Team Canada addition, but he should still have a great shot. Again, the focus will probably be on Bouchard’s track record over the past few seasons. He’s projected to get over 50 points again this season, but he is coming off a stellar 82-point season last year and has torched the Stanley Cup Playoffs for two straight seasons. He has a mindboggling 49 points in 37 playoff games since 2022-23. Bouchard has proven to step up when the games matter most, and Canada’s brass will be aware of that.For the past two months, the market focus has, naturally, been on FII selling and the resultant correction. In the process, the street seems to have forgotten another reason for the current volatility: The fast-approaching deadline for implementing the measures the market regulator SEBI ordered to curb rising speculation. These measures were announced mid-year, to be implemented towards the end of 2024. So, there is a technical reason as well
Ross County 2, Motherwell 1 St. Johnstone 1, Kilmarnock 0 Rangers 1, Dundee United 1 St Mirren FC 2, Aberdeen 1 Dundee 4, Hibernian FC 1 Hearts 1, Celtic 4 Hibernian FC 3, Aberdeen 3 Celtic vs. Ross County, 10 a.m. Dundee United vs. St Mirren FC, 10 a.m. Kilmarnock vs. Dundee, 10 a.m. Motherwell vs. Hibernian FC, 10 a.m. St. Johnstone vs. Rangers, 7 a.m. Hearts vs. Aberdeen, 10 a.m. Dundee vs. Motherwell, 2:45 p.m. Rangers vs. Kilmarnock, 2:45 p.m. Aberdeen vs. Celtic, 3 p.m. Aberdeen vs. St. Johnstone, 10 a.m. Celtic vs. Hibernian FC, 10 a.m. Dundee United vs. Kilmarnock, 10 a.m. Hearts vs. Dundee, 10 a.m. St Mirren FC vs. Motherwell, 10 a.m.Aston Villa had a stoppage-time goal disallowed as they drew 0-0 with Juventus in the Champions League . Morgan Rogers looked to have given Unai Emery’s side another famous win when he slammed a loose ball home at the death, but referee Jesus Gil Manzano ruled Diego Carlos to have fouled Juve goalkeeper Michele Di Gregorio and the goal was chalked off. It was a disappointment for Villa, who remain unbeaten at home in their debut Champions League campaign and are still in contention to qualify automatically for the last 16. Emiliano Martinez had earlier displayed why he was named the best goalkeeper in the world as his wonder save kept his side level in the second half. The Argentina international paraded his two Yashin Trophies on the pitch before kick-off at Villa Park and then showed why he won back-to-back FIFA awards when he denied Francisco Conceicao. Before Rogers’ moment of drama in the fourth minute of added time, the closest Villa came to scoring was in the first half when Lucas Digne’s free-kick hit the crossbar. But a draw was a fair result which leaves Villa out of the top eight on goal difference and Juventus down in 19th. Before the game Emery called Juventus one of the “best teams in the world, historically and now”, but this was an Italian side down to the bare bones. Only 14 outfield players made the trip from Turin, with striker Dusan Vlahovic among those who stayed behind. The opening 30 minutes were forgettable before the game opened up. Ollie Watkins, still chasing his first Champions League goal, had Villa’s first presentable chance as he lashed an effort straight at Di Gregorio. Matty Cash then had a vicious effort from the resulting corner which was blocked by Federico Gatti and started a counter-attack which ended in Juventus striker Timothy Weah. Villa came closest to breaking the deadlock at the end of the first half when Digne’s 20-yard free-kick clipped the top of the crossbar and went over. Martinez then produced his brilliant save just after the hour. A corner made its way through to the far post where Conceicao was primed to head in at the far post, but Martinez sprawled himself across goal to scoop the ball away. Replays showed most of the ball went over the line, but the Argentinian got there with millimetres to spare. At the other end another fine goal-line block denied John McGinn as Manuel Locatelli got his foot in the way with Di Gregorio beaten. The game looked to be petering out until a last-gasp free-kick saw Rogers slam home, but whistle-happy official Gil Manzano halted the celebrations by ruling the goal out.
Trump team signs agreement to allow Justice to conduct background checks on nominees, staff
NEW YORK (AP) — U.S. stock indexes reached more records after tech companies talked up how much artificial intelligence is boosting their results. The S&P 500 climbed 0.6% Wednesday to add to what looks to be one of its best years of the millennium. The Dow Jones Industrial Average gained 0.7%, while the Nasdaq composite added 1.3% to its own record. Salesforce pulled the market higher after highlighting its artificial-intelligence offering for customers. Marvell Technology jumped even more after saying it’s seeing strong demand from AI. Treasury yields eased, while bitcoin climbed after President-elect Donald Trump nominated a crypto advocate to head the Securities and Exchange Commission. THIS IS A BREAKING NEWS UPDATE. AP’s earlier story follows below. Javascript is required for you to be able to read premium content. Please enable it in your browser settings.ACT's 'A Whynot Christmas Carol' Deconstructs a Dickens Classic, to Evocative EndsThe Latest: Suspect in United Healthcare CEO's killing charged with weapons, forgery, other charges
